We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.34B
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
+21.27%
1 Year Est. Return
+30.42%
3 Year Est. Return
+101.7%
5 Year Est. Return
+135.96%
10 Year Est. Return
+427.28%
AUM
$939M
AUM Growth
+$251M
Cap. Flow
+$120M
Cap. Flow %
12.78%
Top 10 Hldgs %
21.99%
Holding
712
New
121
Increased
382
Reduced
142
Closed
42

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.15M
2
JPM icon
JPMorgan Chase
JPM
+$2.69M
3
MSFT icon
Microsoft
MSFT
+$2.67M
4
CVS icon
CVS Health
CVS
+$2.62M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 19.12%
2 Healthcare 13.83%
3 Financials 9.28%
4 Industrials 8.81%
5 Consumer Staples 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
76
Citigroup
C
$222B
$2.82M 0.3%
55,228
-2,922
-5% -$139K
ZTS icon
77
Zoetis
ZTS
$31.6B
$2.79M 0.3%
20,425
+2,389
+13% +$312K
ABB
78
DELISTED
ABB Ltd
ABB
$2.79M 0.3%
122,770
+24,222
+25% +$466K
SBUX icon
79
Starbucks
SBUX
$118B
$2.79M 0.3%
37,937
+30,012
+379% +$2.26M
JPST icon
80
JPMorgan Ultra-Short Income ETF
JPST
$40B
$2.75M 0.29%
54,074
+4,555
+9% +$229K
BP icon
81
BP
BP
$113B
$2.74M 0.29%
117,715
+12,337
+12% +$296K
GIS icon
82
General Mills
GIS
$19.2B
$2.71M 0.29%
44,048
+361
+0.8% +$21.8K
LLY icon
83
Eli Lilly
LLY
$1.07T
$2.7M 0.29%
16,444
-1,989
-11% -$305K
GLW icon
84
Corning
GLW
$126B
$2.7M 0.29%
104,131
+12,553
+14% +$285K
IHI icon
85
iShares US Medical Devices ETF
IHI
$3.02B
$2.68M 0.29%
60,768
+27,834
+85% +$1.19M
CAT icon
86
Caterpillar
CAT
$409B
$2.49M 0.27%
19,626
-1,269
-6% -$150K
VIG icon
87
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.47M 0.26%
21,043
+1,127
+6% +$128K
GLD icon
88
SPDR Gold Trust
GLD
$131B
$2.45M 0.26%
14,641
-585
-4% -$94.4K
ARKK icon
89
ARK Innovation ETF
ARKK
$5.89B
$2.44M 0.26%
34,228
+1,600
+5% +$93.6K
UL icon
90
Unilever
UL
$131B
$2.39M 0.25%
38,924
+10,009
+35% +$598K
IBB icon
91
iShares Biotechnology ETF
IBB
$9.31B
$2.36M 0.25%
17,273
+8,810
+104% +$1.12M
MDLZ icon
92
Mondelez International
MDLZ
$77.7B
$2.36M 0.25%
46,147
+15,325
+50% +$787K
GILD icon
93
Gilead Sciences
GILD
$161B
$2.33M 0.25%
30,207
+6,551
+28% +$502K
TMO icon
94
Thermo Fisher Scientific
TMO
$211B
$2.26M 0.24%
6,232
-322
-5% -$108K
DOW icon
95
Dow Inc
DOW
$21.6B
$2.25M 0.24%
55,577
+4,273
+8% +$156K
KMI icon
96
Kinder Morgan
KMI
$73.1B
$2.21M 0.24%
145,126
+10,183
+8% +$155K
AME icon
97
Ametek
AME
$55.5B
$2.2M 0.23%
24,671
+11,831
+92% +$992K
ILMN icon
98
Illumina
ILMN
$29.4B
$2.15M 0.23%
5,964
-410
-6% -$132K
KTCC icon
99
Key Tronic
KTCC
$40.3M
$2.12M 0.23%
397,800
+5,250
+1% +$22.3K
PYPL icon
100
PayPal
PYPL
$49.5B
$2.09M 0.22%
12,049
-774
-6% -$107K

Similar funds

Moors & Cabot's Q2 2020 Portfolio in Review

As of Q2 2020, Moors & Cabot held 712 positions worth $939M, up 36% from $688M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Moors & Cabot deployed $120M of net new capital in Q2 2020, opening 121 new positions and adding to 382 existing holdings. Its largest new stake was Slack Technologies, Inc.: 61,274 shares worth $1.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was First Trust Dorsey Wright Focus 5 ETF, an estimated $1.67M trimmed.

  • Moors & Cabot's largest Q2 2020 buy was Slack Technologies, Inc.: 61,274 shares worth $1.9M.
  • Moors & Cabot added most to Procter & Gamble in Q2 2020, an estimated $3.15M increase.
  • Moors & Cabot's biggest Q2 2020 reduction was First Trust Dorsey Wright Focus 5 ETF, cutting an estimated $1.67M.
  • Moors & Cabot fully exited Cincinnati Bell Inc. DEP SHS in Q2 2020, selling an estimated $2.36M.
  • Moors & Cabot's ten largest holdings make up 22% of its $939M portfolio in Q2 2020.
  • Moors & Cabot opened 121 new positions and closed 42 in Q2 2020.
  • Moors & Cabot's portfolio value rose 36% quarter-over-quarter to $939M.

Based on Moors & Cabot's 13F filing for Q2 2020, filed 13 Aug 2020.